Inflammatory Bowel Disease (IBD) is the chronic or recurring immune response and inflammation of the gastrointestinal tract, with the two main types being Ulcerative Colitis (UC) and Crohn’s Disease (CD). It is estimated that there are over 3 million people in Europe suffering from IBD, according to estimates from The European Federation of Crohn’s & Ulcerative Colitis Associations (EFCCA), costing up to €5.6 billion per year in direct healthcare costs. And the societal costs are even greater in terms of diminished productivity, as well as psychological issues, such as anxiety and depression. People with IBD experience episodes of abdominal cramps and pain, bleeding from the rectum, weight loss, fever and fatigue. Although there is no cure for IBD, its symptoms and impact on a patient’s life can be minimized by appropriate medical care and changes in behavior. Sidekick is a digital medication management and lifestyle change platform. We are partnering with the world’s leading pharmaceutical companies, complementing traditional drug treatments, helping IBD patients manage their symptoms and improve their quality of life.